Humanis
Humanis, officially known as Humanis Life, is a pioneering company headquartered in Turkey (TR) that operates primarily in the health and wellness industry. Founded in 2018, Humanis has quickly established itself as a leader in providing innovative solutions that enhance the quality of life for individuals. The company focuses on developing advanced health technologies and personalised wellness programmes, setting itself apart with a commitment to scientific research and user-centric design. With a strong presence in Europe and the Middle East, Humanis has achieved notable milestones, including partnerships with leading health institutions and recognition for its contributions to digital health. Humanis continues to solidify its market position through its unique offerings, which combine cutting-edge technology with a holistic approach to health, making it a trusted name in the wellness sector.
DitchCarbon Score
How does Humanis's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Humanis's score of 3 is lower than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Humanis's reported carbon emissions
Humanis Sağlık A.Ş., headquartered in Turkey, currently does not report specific carbon emissions data. However, the company is committed to reducing its carbon footprint and has made significant climate commitments. As of July 2023, Humanis has established near-term reduction targets, although specific numerical goals have not been disclosed. The company is actively engaged in the pharmaceuticals, biotechnology, and life sciences sector, which is increasingly focused on sustainability and reducing greenhouse gas emissions. While Humanis has not committed to a net-zero target, its commitment to near-term reductions indicates a proactive approach to addressing climate change. The company is part of a broader industry movement towards sustainability, reflecting the growing importance of environmental responsibility in the pharmaceutical sector.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Humanis is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
